Skip to content
Search

Latest Stories

Pharmacy First data issues resolved, submission deadline extended

Pharmacy First data issues resolved, submission deadline extended

CPE urges the government and the NHS to prevent any further teething issues and provide pharmacies with the wider funding and support

Pharmacy owners were informed via email on Wednesday that data issues in the Manage Your Service (MYS) portal have been resolved, and they can submit their February Pharmacy First claims by 11.59 pm on Monday 25 March 2024.


Earlier, the NHS Business Services Authority (NHSBSA) had clarified that discrepancies in the figures for urgent medicine consultations were not caused by a flaw in the MYS system, but due to the data received from IT system suppliers.

In the latest email sent to pharmacy owners, the NHSBSA has confirmed that the IT system suppliers have resolved issues with the declaration data they supplied to the portal.

Those who still find their totals inaccurate are asked to contact NHSBSA immediately so that the problem can be investigated before the above deadline.

Pharmacy owners are being assured that the revised deadline will not have an impact on the payment schedule, and they will receive their compensation on 1st May as expected.

Later submissions will be accepted until 5 March 2024, but it will result in delayed payments. Any submissions made after three months will not be accepted, as announced by NHS England and the Department of Health and Social Care.

Janet Morrison, chief executive of Community Pharmacy England (CPE), acknowledged the significant stress pharmacy owners and their teams have faced over the past few weeks due to IT issues.

She said that the committee will be working with DHSC and NHSE to review data to understand “what impact there may have been on target consultations and wider confidence in the service.”

“We are also pressing for better programme management and stakeholder communications to ensure that contractors are not left in the dark to cope with IT issues when they impact their businesses,” she added.

Highlighting that Pharmacy First is critical for pharmacies, patients and the wider NHS, Morrison underscored the need for addressing teething issues and providing pharmacies with wider funding and support to ensure smooth implementation of the scheme.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less